Lv6
1630 积分 2022-01-27 加入
Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
15小时前
待确认
Practical Approach to Diagnosis and Management of IL-1-Mediated Autoinflammatory Diseases (CAPS, TRAPS, MKD, and DIRA)
1天前
待确认
The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study
3天前
已完结
Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease
7天前
已完结
Comparison of the efficacy and safety of biological agents in patients with systemic juvenile idiopathic arthritis: A Bayesian network meta-analysis of randomized controlled trials
16天前
已完结
Outcomes of sorafenib treatment of advanced renal cell carcinoma according to IMDC risk criteria: analysis of Japanese real-world data from postmarketing all-patient surveillance of sorafenib
17天前
已完结
Comparative Effectiveness of First-Line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors According to IMDC Risk Groups in Metastatic Renal Cell Carcinoma: A Meta-Analysis
18天前
已完结
Optimizing Treatment Selection in Advanced Renal Cell Carcinoma via IMDC Risk Group Stratification
18天前
已完结
Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery
21天前
已完结
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
21天前
已完结
皖公网安备34019202002308
